Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
DCFirst Claim
1. A process for manufacturing a resulting pharmaceutical film suitable for commercialization and regulatory approval said resulting pharmaceutical film having a substantially uniform distribution of a desired amount of a pharmaceutical active in individual doses of the resulting pharmaceutical film, comprising the steps of:
- (a) forming a visco-elastic polymer matrix by mixing, said matrix comprising a polymer selected from the group consisting of water-soluble polymers, water-swellable polymers and combinations thereof, a solvent selected from the group consisting of water, a polar organic solvent and combinations thereof, and pharmaceutical active, which polymer matrix during film casting is a shear-thinning pseudoplastic fluid when exposed to shear rates of 10-105 sec−
1, said polymer matrix having a substantially uniform distribution of said pharmaceutical active;
(b) casting said polymer matrix;
(c) conveying said polymer matrix through a drying apparatus and drying said polymer matrix, to rapidly remove at least a portion of said solvent from said matrix to form a visco-elastic film having said pharmaceutical active substantially uniformly distributed throughout by rapidly increasing the viscosity of said polymer matrix upon initiation of drying within about the first 4 minutes to maintain said uniform distribution of said pharmaceutical active by locking-in or substantially preventing migration of said pharmaceutical active, wherein the temperature of the polymer matrix is 100°
C. or less, wherein content uniformity of said active in substantially equal sized individual dosage units of said visco-elastic film is such that the amount of the active varies by no more than 10% from the desired amount; and
(d) forming the resulting pharmaceutical film having a water content of 10% or less and a thickness of about 0.1 mils to about 10 mils from said visco-elastic film, wherein said resulting pharmaceutical film having said substantially uniform distribution of pharmaceutical active by said locking-in or substantially preventing migration of said pharmaceutical active is maintained, such that content uniformity of said active in substantially equal sized individual dosage units of said resulting pharmaceutical film is such that the amount of the active varies by no more than 10% from the desired amount.
7 Assignments
Litigations
1 Petition
Accused Products
Abstract
The present invention relates to rapid dissolve thin film drug delivery compositions for the oral administration of active components. The active components are provided as taste-masked or controlled-release coated particles uniformly distributed throughout the film composition. The compositions may be formed by wet casting methods, where the film is cast and controllably dried, or alternatively by an extrusion method.
597 Citations
29 Claims
-
1. A process for manufacturing a resulting pharmaceutical film suitable for commercialization and regulatory approval said resulting pharmaceutical film having a substantially uniform distribution of a desired amount of a pharmaceutical active in individual doses of the resulting pharmaceutical film, comprising the steps of:
-
(a) forming a visco-elastic polymer matrix by mixing, said matrix comprising a polymer selected from the group consisting of water-soluble polymers, water-swellable polymers and combinations thereof, a solvent selected from the group consisting of water, a polar organic solvent and combinations thereof, and pharmaceutical active, which polymer matrix during film casting is a shear-thinning pseudoplastic fluid when exposed to shear rates of 10-105 sec−
1, said polymer matrix having a substantially uniform distribution of said pharmaceutical active;(b) casting said polymer matrix; (c) conveying said polymer matrix through a drying apparatus and drying said polymer matrix, to rapidly remove at least a portion of said solvent from said matrix to form a visco-elastic film having said pharmaceutical active substantially uniformly distributed throughout by rapidly increasing the viscosity of said polymer matrix upon initiation of drying within about the first 4 minutes to maintain said uniform distribution of said pharmaceutical active by locking-in or substantially preventing migration of said pharmaceutical active, wherein the temperature of the polymer matrix is 100°
C. or less, wherein content uniformity of said active in substantially equal sized individual dosage units of said visco-elastic film is such that the amount of the active varies by no more than 10% from the desired amount; and(d) forming the resulting pharmaceutical film having a water content of 10% or less and a thickness of about 0.1 mils to about 10 mils from said visco-elastic film, wherein said resulting pharmaceutical film having said substantially uniform distribution of pharmaceutical active by said locking-in or substantially preventing migration of said pharmaceutical active is maintained, such that content uniformity of said active in substantially equal sized individual dosage units of said resulting pharmaceutical film is such that the amount of the active varies by no more than 10% from the desired amount. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)
-
-
27. A process for manufacturing a resulting pharmaceutical film suitable for commercialization and regulatory approval said resulting pharmaceutical film having a substantially uniform distribution of a desired amount of a pharmaceutical active in individual doses of the resulting pharmaceutical film, comprising the steps of:
-
(a) forming a visco-elastic polymer matrix by mixing, said matrix comprising a polymer selected from the group consisting of water-soluble polymers, water-swellable polymers and combinations thereof, a solvent selected from the group consisting of water, a polar organic solvent and combinations thereof, and pharmaceutical active, which polymer matrix during film casting is a shear-thinning pseudoplastic fluid when exposed to shear rates of 10-105 sec−
1, said polymer matrix having a substantially uniform distribution of said pharmaceutical active;(b) casting said polymer matrix; (c) conveying said polymer matrix through a drying apparatus and drying said polymer matrix, to rapidly remove at least a portion of said solvent from said matrix to form a visco-elastic film having said pharmaceutical active substantially uniformly distributed throughout by rapidly increasing the viscosity of said polymer matrix upon initiation of drying within about the first 4 minutes to maintain said uniform distribution of said pharmaceutical active by locking-in or substantially preventing migration of said pharmaceutical active, wherein the temperature of the polymer matrix is 100°
C. or less, wherein any top air flow does not overcome the inherent viscosity of the visco-elastic film and any top air flow is insufficient to cause one or more of the following;
(i) surface skinning prior to drying the depth of the film;
(ii) surface rippling;
(iii) self-aggregation of components;
(iv) non-uniformity in thickness of the film; and
(v) non-uniformity of mass per unit volume, wherein content uniformity of said active in substantially equal sized individual dosage units of said visco-elastic film is such that the amount of the active varies by no more than 10% from the desired amount; and(d) forming the resulting pharmaceutical film from said visco-elastic film, wherein said resulting pharmaceutical film having said substantially uniform distribution of pharmaceutical active by said locking-in or substantially preventing migration of said pharmaceutical active is maintained, such that content uniformity of said active in substantially equal sized individual dosage units of said resulting pharmaceutical film is such that the amount of the active varies by no more than 10% from the desired amount. - View Dependent Claims (28, 29)
-
Specification